ISDA

Deposition Date 2013-05-09

Release Date 2014-04-30

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4KNB

Keywords:

TRANSFERASE

Title:

C-Met in complex with OSI ligand

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Insecta

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.40 Å

R-Value Free:

0.28

R-Value Work:

0.23

R-Value Observed:

0.24

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Hepatocyte growth factor receptor
Gene (Uniprot):MET
Chain IDs:A, B, C, D
Chain Length:287
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:P08581 Pfam ID:PF07714 EC:2.7.10.1

Ligand Molecules

1RU

GBL

Primary Citation

Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases.

Steinig, A.G, Li, A.H, Wang, J, Chen, X, Dong, H, Ferraro, C, Jin, M, Kadalbajoo, M, Kleinberg, A, Stolz, K.M, Tavares-Greco, P.A, Wang, T, Albertella, M.R, Peng, Y, Crew, L, Kahler, J, Kan, J, Schulz, R, Cooke, A, Bittner, M, Turton, R.W, Franklin, M, Gokhale, P, Landfair, D, Mantis, C, Workman, J, Wild, R, Pachter, J, Epstein, D, Mulvihill, M.J.Show

Bioorg.Med.Chem.Lett. 23 4381 4387 (2013)

PMID: 23773865 DOI: 10.1016/j.bmcl.2013.05.074

Abstact

A series of novel 6-aminofuro[3,2-c]pyridines as kinase inhibitors is described, most notably, OSI-296 (6). We discuss our exploration of structure-activity relationships and optimization leading to OSI-296 and disclose its pharmacological activity against cMET and RON in cellular assays. OSI-296 is a potent and selective inhibitor of cMET and RON kinases that shows in vivo efficacy in tumor xenografts models upon oral dosing and is well tolerated.

Legend

Protein

Chemical

Disease

Primary Citation of related structures